Applications are invited for recruitment of various managerial positions or career in IIPH Shillong Meghalaya in 2026. Indian Institute of Pu ...

Columbia University Mailman School of Public Health has received an award as part of the PROactive Solutions for Prolonging Resilience (PROSPR) program within the Advanced Research Projects Agency for ...

Western University researchers and affiliate hospitals have been awarded $10.7 million in competitive federal grants to fund 14 interdisciplinary projects aimed at solving various healthcare ...

Harness Therapeutics nominates HRN001, a first-in-class drug candidate for Huntington’s disease and establishes clinical advisory board: Cambridge, UK Tuesday, February 17, 2026 ...

Trial Evaluates Solution to Sample Tampering in Point-of-Care Urine Drug Testing The EvoClinical team is proud to ...

Members of the Rapid Randomized Controlled Trial Lab collaborate with frontline staff throughout NYU Langone to improve care.

Pelareorep is also showing strong results in anal cancer, where third-line patients achieved a 29% response rate with responses lasting around 17 months in a setting with no FDA-approved treatments.